Almac Group Receives Annual Industrial Award from the Institute of Chemistry of Ireland
Professor Tom Moody accepts accolade on behalf of Biocatalysis Team
Craigavon, N.I., 05 December 2017 – Almac Group, the global contract development and manufacturing organisation is delighted to announce Professor Tom Moody, VP Technology Development & Commercialisation at Almac & Arran Chemical Company, has received the prestigious Institute of Chemistry of Ireland Industrial Chemistry Award 2017.
Judges awarded Tom and his team with the honour based on the excellence demonstrated within Almac Sciences’ enzyme technology development research program. This is achieved through the unique collaboration between the biocatalysis team within Almac, headquartered in Northern Ireland, and Arran Chemical Company, Athlone, a member of the Almac Group since 2015.
The award was established to recognise the achievement of an individual chemist, or team of chemists, for making a significant contribution to the chemical or pharmaceutical industry in Ireland and the recipient is invited to present the annual Eva Philbin Lecture – a series of keynote lectures in education institutions across Ireland. Eva Philbin was the first woman president of the Institute of Chemistry of Ireland. She began her career as a chemist in industry in 1939, and was chief chemist at two commercial companies before joining the chemistry department at University College Dublin in 1945.
Professor Moody presented his Eva Philbin lecture on the subject of “Enzyme “feeds” rapid development and commercialisation” during the award ceremony held at the Albert Lecture Theatre, Royal College of Surgeons in Dublin, Ireland on 4th December.
Tom leads a team of biocatalysis experts and is a distinguished chemist with an international reputation. He graduated from The Queen’s University Belfast with a 1st Class BSc(Hons) in chemistry before returning to gain a Ph.D. in Physical Organic chemistry. He has also completed a Masters Degree in Business graduating with distinction specialising in business strategy. His work has earned him numerous accolades and is co-author and author of >60 publications and patents. He is also an honorary Professor at Queen’s University of Belfast in the area of biocatalysis.
Upon receiving the award Professor Moody commented: “On behalf of the team at Almac Sciences and Arran Chemical Company, I am thrilled to receive this prestigious award. It is a true honour to be recognised in this way by the Institute of Chemistry and be invited to present a lecture in honour of Eva Philbin who is undoubtedly one of the most inspirational chemists of our lifetime. Special thanks to my entire team for their dedication, commitment and passion which has made winning this award possible.”
About Almac Group
‘Partnering to Advance Human Health’
The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally. The services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation that has organically grown over almost 50 years and now employs in excess of 5,000 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).